![]() ![]() | Van Hulst, G. (2024). Unraveling the influence of Interleukin-5 on eosinophil development: Contribution to a better understanding of precision therapies for severe eosinophilic asthma [Doctoral thesis, Laboratory of Cellular and Molecular Immunology]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/325557 |
![]() ![]() | Jorssen, J.* , Van Hulst, G.* , Mollers, K., Pujol, J., Petrellis, G., Baptista, A. P., Schetters, S., Baron, F., Caers, J., Lambrecht, B. N., Dewals, B. G., Bureau, F.* , & Desmet, C.*. (2024). Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification. Immunity. doi:10.1016/j.immuni.2024.04.027 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Van Hulst, G., Jorssen, J., Jacobs, N., Henket, M., Louis, R., Schleich, F., Bureau, F., & Desmet, C. (2022). Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma. European Respiratory Journal. doi:10.1183/13993003.00935-2021 ![]() |
![]() ![]() | Van Hulst, G., Bureau, F., & Desmet, C. (2021). Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity? International Journal of Molecular Sciences, 22 (18). doi:10.3390/ijms221810150 ![]() |
![]() ![]() | Van Hulst, G., Batugedara, H. M., Jorssen, J., Louis, R., Bureau, F., & Desmet, C. (2020). Eosinophil diversity in asthma. Biochemical Pharmacology, 179. doi:10.1016/j.bcp.2020.113963 ![]() |
![]() ![]() | Arnone, M., Van Hulst, G., Desmet, C., Bureau, F., Jacobs, N., Gerday, S. (Other coll.), HENKET, M. (Other coll.), & LOUIS, R. (Other coll.). (21 May 2019). Building a comprehensive map of immune cell populations in sputum from patients with eosinophilic asthma [Poster presentation]. EDT-Immunology day. |